Introduction to FASB Statement No. 2
The FASB Statement No. 2, Accounting for Research and Development Costs, was issued in 1974 to provide guidance on accounting for research and development expenses. This statement requires companies to expense R&D costs as incurred, rather than capitalizing them as assets.
The statement applies to all companies that incur R&D costs, including those in the technology, pharmaceutical, and manufacturing industries. By expensing R&D costs, companies can match the costs with the benefits they provide, resulting in more accurate financial reporting.
Scope and Application of FASB Statement No. 2
FASB Statement No. 2 applies to all types of R&D costs, including personnel costs, materials and equipment costs, and contract services costs. The statement also provides guidance on accounting for R&D costs incurred under government grants and contracts.
The statement does not apply to costs associated with the production of commercial products, such as quality control and routine maintenance costs. Companies must carefully distinguish between R&D costs and other types of costs to ensure accurate financial reporting.
Accounting for R&D Costs Under FASB Statement No. 2
Under FASB Statement No. 2, companies must expense R&D costs as incurred, rather than capitalizing them as assets. This means that R&D costs are recognized as expenses on the income statement in the period in which they are incurred.
Companies must also disclose their R&D costs in the financial statements, including the amount of R&D costs expensed during the period and the amount of R&D costs capitalized as assets. This disclosure provides stakeholders with information about the company's R&D activities and their impact on financial performance.
Impact of FASB Statement No. 2 on Financial Reporting
FASB Statement No. 2 has a significant impact on financial reporting for companies that incur R&D costs. By expensing R&D costs, companies can match the costs with the benefits they provide, resulting in more accurate financial reporting.
The statement also provides stakeholders with information about a company's R&D activities and their impact on financial performance. This information can be useful in evaluating a company's financial health and making investment decisions.
Conclusion and Future Developments
In conclusion, FASB Statement No. 2 provides guidance on accounting for R&D costs and has a significant impact on financial reporting for companies that incur these costs. Companies must carefully apply the statement to ensure accurate financial reporting and compliance with accounting standards.
The FASB continues to monitor and update accounting standards, including those related to R&D costs. Companies must stay informed about these developments and adapt their accounting practices accordingly to ensure compliance and accurate financial reporting.
Frequently Asked Questions
What is the purpose of FASB Statement No. 2?
The purpose of FASB Statement No. 2 is to provide guidance on accounting for research and development expenses.
What types of costs are included in R&D costs under FASB Statement No. 2?
R&D costs include personnel costs, materials and equipment costs, and contract services costs.
How are R&D costs accounted for under FASB Statement No. 2?
R&D costs are expensed as incurred, rather than capitalized as assets.
What is the impact of FASB Statement No. 2 on financial reporting?
FASB Statement No. 2 provides stakeholders with information about a company's R&D activities and their impact on financial performance.
Are there any exceptions to the requirement to expense R&D costs under FASB Statement No. 2?
Yes, the statement does not apply to costs associated with the production of commercial products, such as quality control and routine maintenance costs.
Where can I find more information about FASB Statement No. 2?
You can find more information about FASB Statement No. 2 on the FASB website or by consulting with a financial accounting expert.